News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
The firm, Phenomix Sciences, anticipates that its test will help drive adoption of medications for obesity at a time when patients are reluctant to take them.
The mass spec-based panel using 26 protein biomarkers is being developed to detect heart failure earlier than with existing BNP-only-based tests.
While results are preliminary, the test could potentially be used in lieu of a liver biopsy.
Biotage will provide systems and consumables from its analytical chemistry portfolio to be sold by Yingsheng under its own brand.
The facility will be mass spec-focused and comprise a service contract lab for developing protein tests and a CAP- and CLIA-certified lab for offering them.
